Professional Summary
Lindsay Puscas is an accomplished clinical research and operations executive with over a decade of experience driving innovation and excellence in the healthcare industry. In her current role as Vice President at ONL Therapeutics, she leverages her deep expertise in clinical trial management, strategic planning, and cross-functional collaboration to advance the company's mission of developing novel ophthalmic therapies.
Experience Summary
Current Role
As Vice President at ONL Therapeutics, Lindsay is responsible for overseeing all aspects of the company's clinical operations, including protocol development, site selection and management, data collection and analysis, and regulatory compliance. She has played a pivotal role in streamlining clinical processes, fostering strong partnerships with key stakeholders, and ensuring the successful execution of multiple clinical studies. Under her leadership, the company has consistently met or exceeded its enrollment targets and delivered high-quality data to support the advancement of its product pipeline.
Career Progression
Prior to her current role, Lindsay served as the Director of Clinical Operations at ONL Therapeutics, where she led a team of clinical research professionals and spearheaded the implementation of robust quality assurance measures. Earlier in her career, she held progressive roles at the University of Michigan Kellogg Eye Center, including Clinical Research Project Manager and Lead Clinical Research Coordinator. In these positions, she honed her expertise in clinical trial design, patient recruitment, and data management, contributing to the successful completion of numerous ophthalmic studies.
Academic Background
Lindsay holds a Bachelor of Science degree in Biomedical Sciences from the University of Michigan, where she graduated with honors. Her academic background and deep knowledge of the healthcare landscape have been instrumental in her ability to navigate the complex regulatory environment and drive evidence-based decision-making.
Areas of Expertise
- Clinical trial management and operations
- Strategic planning and project management
- Cross-functional team leadership and collaboration
- Regulatory compliance and quality assurance
- Data analysis and interpretation
- Stakeholder engagement and relationship building
Professional Impact
Throughout her career, Lindsay has demonstrated a consistent track record of driving measurable improvements in clinical trial efficiency and data quality. Her contributions have been instrumental in advancing the development of novel ophthalmic therapies, ultimately improving patient outcomes and advancing the field of ophthalmology.
Conclusion
With her extensive experience, proven leadership skills, and unwavering commitment to excellence, Lindsay Puscas is poised to continue making significant contributions to the healthcare industry. As Vice President at ONL Therapeutics, she is well-equipped to guide the company's clinical research initiatives and support the development of innovative solutions that address unmet medical needs.
